Sign in

CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
753056237
Phone
360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
  1. 8-K Event Regulation FD disclosure
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Executive or director change · Regulation FD disclosure
  5. 8-K Event Regulation FD disclosure
  6. S-3 Offering Registration Statement
  7. 8-K Event Other events
  8. UPLOAD Other SEC-generated Letter
  9. 4 Option exercise Chairman & CMO acquired 166,000 shares (option exercise)
  10. 8-K Event Material agreement · Unregistered share sale
  11. EFFECT Other Notice of Effectiveness
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. S-3 Offering Registration Statement
  15. 10-Q Report Quarterly Report
  16. EFFECT Other Notice of Effectiveness
  17. S-3/A Offering Registration Statement
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. 4 Open-market sale Chief Financial Officer sold 711,801 shares at an average $6.23 ($4,437,557)

Page 23 of 71 · 1,401 filings